-
Mashup Score: 0
V114, a 15-valent pneumococcal vaccine, was safe and effective in children with sickle cell disease in a phase 3 trial.
Source: Docwire NewsCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0How Can Artificial Intelligence Improve Health Care? | Docwire News - 9 month(s) ago
Kaushik Gune, US head of Healthcare for Huma Therapeutics Limited, spoke with DocWire about Huma.AI, Huma’s generative AI platform for health care providers.
Source: Docwire NewsCategories: Latest Headlines, Partners & KOLsTweet-
Kaushik Gune, US head of Healthcare for Huma Therapeutics Limited, spoke about artificial intelligence in health care and the company’s groundbreaking AI platform for health care providers. #artificialintelligence #healthcare https://t.co/tlDl4OH5Rt https://t.co/3anyr57aDL
-
-
Mashup Score: 0Fruquintinib Plus Toripalimab Is an Effective Third-Line Treatment of Advanced Colorectal Cancer | Docwire News - 9 month(s) ago
Fruquintinib combined with the anti-programmed death-1 antibody toripalimab is effective in treating advanced colon cancer.
Source: Docwire NewsCategories: Latest Headlines, Partners & KOLsTweet-
A recent study suggested that fruquintinib combined with toripalimab has a better effect compared with fruquintinib alone in the third-line treatment of patients with refractory metastatic advanced #colorectalcancer. #fruquintinib https://t.co/pNTtG9UYLe https://t.co/ZWrJqt50PD
-
-
Mashup Score: 0Heart Failure | Docwire News - 9 month(s) ago
View the latest research on heart failure for cardiologists, including updates to heart failure guidelines, treatment algorithms, clinical trials, and more.
Source: Docwire NewsCategories: Latest Headlines, Partners & KOLsTweet-
Check out the @mydocwire #HeartFailure knowledge hub to catch up on all things @CardioNerds & #HeartSuccess! https://t.co/aHguwMXDBY
-
-
Mashup Score: 14Dr. Nyal Borges Explains Why Microcatheters are Necessary in Interventional Cardiology | Docwire News - 10 month(s) ago
Dr. Hady Lichaa speaks with Dr. Nyal Borges about microcatheters, and why there are essential in interventional cardiology.
Source: Docwire NewsCategories: Cardiologists, Latest HeadlinesTweet-
RT @HadyLichaaMD: #CoronaryMicrocatheter decision in #CHIP with #CTOexpert @nyalborgesmd Part 1/2 https://t.co/5fGA1UW3h2 @SripalBangal…
-
-
Mashup Score: 0Case Study: Pulmonary Embolism Mimics Abdominal Pain in a Patient With Sickle Cell Disease | Docwire News - 10 month(s) ago
Pulmonary embolism is challenging to diagnose due to its nonspecific symptoms, including abdominal pain.
Source: Docwire NewsCategories: General Medicine News, Latest HeadlinesTweet-
Pulmonary embolism is challenging to diagnose due to its nonspecific symptoms, including abdominal pain. Researchers assessed a patient with sickle cell disease who presented with abdominal pain and was found to have a PE. #pulmonaryembolism #casestudy https://t.co/FrW9zA4pfB https://t.co/TsUXmSTYoZ
-
-
Mashup Score: 0Oral Therapy Use Has Risen in Patients With MS | Docwire News - 10 month(s) ago
Disease-modifying therapies for MS have shifted substantially since 2001, with more patients now taking oral medications.
Source: Docwire NewsCategories: General Medicine News, Latest HeadlinesTweet-
Disease-modifying therapies for multiple sclerosis have shifted substantially since 2001, with more patients now taking oral medications. #MS https://t.co/4vUP397EWa https://t.co/hEOfooJu0j
-
-
Mashup Score: 0Can CPAP Improve High-Risk Pregnancies With OSA? | Docwire News - 10 month(s) ago
Continuous positive airway pressure therapy improved blood pressure and preeclampsia rates in high-risk pregnancies with OSA.
Source: Docwire NewsCategories: General Medicine News, Latest HeadlinesTweet-
Continuous positive airway pressure therapy improved blood pressure and preeclampsia rates in high-risk pregnancies with obstructive sleep apnea. #CPAP #OSA https://t.co/fVGnsbZ86z https://t.co/4I4OTi827d
-
-
Mashup Score: 0FDA Grants Full Approval to Game-Changing Drug for Alzheimer Disease | Docwire News - 10 month(s) ago
The FDA converted the novel drug Leqembi, the first therapy proven to slow the course of Alzheimer disease, to full approval.
Source: Docwire NewsCategories: Latest Headlines, Partners & KOLsTweet-
Significant news. This week FDA converted the novel drug Leqembi, the first therapy proven to slow the course of Alzheimer disease, to full approval. #Alzheimerdisease #FDAapproval https://t.co/u71iDguGxY https://t.co/aEMIYmsALk
-
-
Mashup Score: 0
The Fellow on Call group continues discussing the management of early stage ER+/HER2-breast cancer.
Source: Docwire NewsCategories: Latest Headlines, Partners & KOLsTweet-
In this episode of @TheFellowOnCall – the group continues discussing the management of early-stage ER+/HER2- #breastcancer. https://t.co/tZRCvI3rLM https://t.co/8n7wCZDEXk
-
V114, a 15-valent pneumococcal vaccine, was safe and effective in children with sickle cell disease in a phase 3 trial. #sicklecell https://t.co/wEl3oBMJiS